The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

435

Participants

Timeline

Start Date

August 29, 2012

Primary Completion Date

October 23, 2013

Study Completion Date

October 23, 2013

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

insulin degludec/liraglutide

Injected subcutaneously (under the skin) once daily. Dose individually adjusted.

DRUG

placebo

Injected subcutaneously (under the skin) once daily.

Trial Locations (87)

1324

Novo Nordisk Investigational Site, Sofia

1431

Novo Nordisk Investigational Site, Sofia

1606

Novo Nordisk Investigational Site, Sofia

5770

Novo Nordisk Investigational Site, Lukovit

7000

Novo Nordisk Investigational Site, Rousse

14224

Novo Nordisk Investigational Site, West Seneca

15009

Novo Nordisk Investigational Site, Beaver

19152

Novo Nordisk Investigational Site, Philadelphia

20852

Novo Nordisk Investigational Site, Rockville

22607

Novo Nordisk Investigational Site, Hamburg

23219

Novo Nordisk Investigational Site, Richmond

23606

Novo Nordisk Investigational Site, Newport News

27070

Novo Nordisk Investigational Site, Gaziantep

28463

Novo Nordisk Investigational Site, Tabor City

29303

Novo Nordisk Investigational Site, Spartanburg

29651

Novo Nordisk Investigational Site, Greer

29669

Novo Nordisk Investigational Site, Pelzer

29681

Novo Nordisk Investigational Site, Simpsonville

30076

Novo Nordisk Investigational Site, Roswell

30318

Novo Nordisk Investigational Site, Atlanta

32934

Novo Nordisk Investigational Site, Melbourne

33136

Novo Nordisk Investigational Site, Miami

33156

Novo Nordisk Investigational Site, Miami

34741

Novo Nordisk Investigational Site, Kissimmee

34752

Novo Nordisk Investigational Site, Istanbul

35100

Novo Nordisk Investigational Site, Izmir

35152

Novo Nordisk Investigational Site, Haifa

35415

Novo Nordisk Investigational Site, Pohlheim

37203

Novo Nordisk Investigational Site, Nashville

37404

Novo Nordisk Investigational Site, Chattanooga

37660

Novo Nordisk Investigational Site, Kingsport

44281

Novo Nordisk Investigational Site, Kfar Saba

45005

Novo Nordisk Investigational Site, Franklin

48098

Novo Nordisk Investigational Site, Troy

48145

Novo Nordisk Investigational Site, Münster

49100

Novo Nordisk Investigational Site, Petah Tikva

52621

Novo Nordisk Investigational Site, Tel Litwinsky

58100

Novo Nordisk Investigational Site, Holon

60031

Novo Nordisk Investigational Site, Gurnee

63017

Novo Nordisk Investigational Site, Chesterfield

63303

Novo Nordisk Investigational Site, Saint Charles

64239

Novo Nordisk Investigational Site, Tel Aviv

66780

Novo Nordisk Investigational Site, Rehlingen-Siersburg

73728

Novo Nordisk Investigational Site, Esslingen am Neckar

75203

Novo Nordisk Investigational Site, Dallas

75251

Novo Nordisk Investigational Site, Dallas

76054

Novo Nordisk Investigational Site, Hurst

77478

Novo Nordisk Investigational Site, Sugar Land

83646

Novo Nordisk Investigational Site, Meridian

84107

Novo Nordisk Investigational Site, Salt Lake City

90057

Novo Nordisk Investigational Site, Los Angeles

90807

Novo Nordisk Investigational Site, Long Beach

91120

Novo Nordisk Investigational Site, Jerusalem

92037

Novo Nordisk Investigational Site, La Jolla

92237

Novo Nordisk Investigational Site, Sulzbach-Rosenberg

92801

Novo Nordisk Investigational Site, Anaheim

92844

Novo Nordisk Investigational Site, Garden Grove

94401

Novo Nordisk Investigational Site, San Mateo

94598

Novo Nordisk Investigational Site, Walnut Creek

110002

Novo Nordisk Investigational Site, Delhi

400008

Novo Nordisk Investigational Site, Mumbai

411030

Novo Nordisk Investigational Site, Pune

560043

Novo Nordisk Investigational Site, Bangalore

590001

Novo Nordisk Investigational Site, Belagavi

600034

Novo Nordisk Investigational Site, Hyderabad

781007

Novo Nordisk Investigational Site, Guwahati

41017-3464

Novo Nordisk Investigational Site, Crestview Hills

03063

Novo Nordisk Investigational Site, Nashua

076444

Novo Nordisk Investigational Site, Lodi

45220-2213

Novo Nordisk Investigational Site, Cincinnati

45040-6815

Novo Nordisk Investigational Site, Mason

73104-5020

Novo Nordisk Investigational Site, Oklahoma City

V5G 1T4

Novo Nordisk Investigational Site, Burnaby

V3S 2N6

Novo Nordisk Investigational Site, Surrey

V8V 3N7

Novo Nordisk Investigational Site, Victoria

N1R 7L6

Novo Nordisk Investigational Site, Cambridge

N6G 2M1

Novo Nordisk Investigational Site, London

M4S 1Y2

Novo Nordisk Investigational Site, Toronto

J7J 2K8

Novo Nordisk Investigational Site, Mirabel

H9R 4S3

Novo Nordisk Investigational Site, Pointe-Claire

J1G 5K2

Novo Nordisk Investigational Site, Sherbrooke

G1N 4V3

Novo Nordisk Investigational Site, Québec

06679

Novo Nordisk Investigational Site, Hohenmölsen

Unknown

Novo Nordisk Investigational Site, Guwahati

00674

Novo Nordisk Investigational Site, Manatí

06110

Novo Nordisk Investigational Site, Ankara

07058

Novo Nordisk Investigational Site, Antalya

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01618162 - The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy | Biotech Hunter | Biotech Hunter